Data from a post hoc analysis of the three-year part of the phase 3a SCALE™ (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial were presented at the first...
from Obesity / Weight Loss / Fitness News From Medical News Today http://ift.tt/1VBDR9i
vendredi 3 juin 2016
weight loss fitnessThree-year data show early response to Saxenda resulted inimprovements in weight loss and cardiometabolic risk factors
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire